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Magnetic Particle Imaging tracks 
the long-term fate of in vivo neural 
cell implants with high image 
contrast
Bo Zheng1, Tandis Vazin1,2,3, Patrick W. Goodwill1,4, Anthony Conway2, Aradhana Verma2, 
Emine Ulku Saritas1, David Schaffer1,2,3 & Steven M. Conolly1,5
We demonstrate that Magnetic Particle Imaging (MPI) enables monitoring of cellular grafts with 
high contrast, sensitivity, and quantitativeness. MPI directly detects the intense magnetization of 
iron-oxide tracers using low-frequency magnetic fields. MPI is safe, noninvasive and offers superb 
sensitivity, with great promise for clinical translation and quantitative single-cell tracking. Here we 
report the first MPI cell tracking study, showing 200-cell detection in vitro and in vivo monitoring of 
human neural graft clearance over 87 days in rat brain.
The evaluation of cell transplantation efficacy and integration currently relies on destructive analytical 
methods like histology or functional improvements that can take months to manifest1. Inaccuracies in 
cell localization during initial delivery are common, with one clinical study reporting a 50% misadmin-
istration rate by experienced operators under ultrasound guidance2. Late detection of such outcomes 
can seriously impact the development of cell-based therapies. Clinical translation and adoption of cell 
therapies could be accelerated by safe, quantitative in vivo imaging methods3.
All standard preclinical imaging modalities have been used to track cells in vivo with varying degrees 
of success3. Bioluminescence and fluorescence imaging are the most common preclinical cell-tracking 
techniques; however, shallow optical penetration depth prevents linear quantification and clinical trans-
lation. Nuclear imaging techniques like Positron Emission Tomography (PET) have excellent tracer sen-
sitivity and depth penetration, but face limitations in tracer half-life and radiation dose.
Clinically, most cell tracking studies have used super-paramagnetic iron oxide (SPIO) labeled cells, 
because SPIO-based methods have minimal effects on cell viability, proliferation, and differentiation4–7, 
along with excellent depth penetration and in vivo persistence measured in months. However, the pri-
mary challenge for MRI-based SPIO cell tracking is that SPIOs induce MRI signal dropouts that are 
difficult to distinguish from tissues with naturally low MRI signal (e.g., bones, tendon, lungs, or any 
tissues near air). Moreover, MRI methods with positive contrast suffer from robustness and sensitivity 
challenges8,9. Until now, no technique has been able to combine high specificity with sensitive and quan-
titative imaging of the distribution and in vivo fate of SPIO-labeled cells3,4.
Magnetic Particle Imaging10,11 is a technique introduced in 2005 by Philips Research that directly 
images the intense magnetization of SPIOs rather than indirectly detecting SPIOs via MRI signal drop-
outs. Briefly, MPI uses a magnetic gradient field to saturate all SPIO magnetization outside a central 
field-free region, which we show as a “field-free line”, or FFL, in Fig. 1a. To produce an image, the FFL 
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is rapidly rastered over an imaging volume via the application of a time varying magnetic field (called 
a “drive field”) produced by an electromagnet. As the FFL traverses a location containing SPIO nano-
particles, the ensemble SPIO magnetization responds by changing in magnitude and orientation12. This 
time-varying particle magnetization induces a voltage in the receiver coil, which can be assigned to the 
instantaneous FFL location to produce a MPI image11,13. Importantly, while the magnetization behavior 
of superparamagnets is nonlinear, the voltage signals generated in MPI are linearly proportional to the 
number of SPIOs at the instantaneous FFL location, enabling quantification of SPIO number13. The 
MPI induction signal is detectable with even a miniscule mass of tracer (5 ng Fe/voxel in our projection 
MPI scanner) because the SPIO magnetization saturates to 600 mT. By comparison, the nuclear para-
magnetism of water in a 7 T MRI scanner is only 27 nT. That is, MPI images a magnetization that is 22 
million times more intense than we image routinely in high-field MRI. Moreover, biological tissue does 
not generate or attenuate the low-frequency magnetic fields used in MPI (10 kHz to 1 MHz)14, giving the 
technique ideal contrast independent of source depth. The combination of these characteristics enables 
MPI to be uniquely suitable for high-contrast, radiation-free cell tracking in vivo15.
To test MPI for tracking cells in vivo, we built two small animal MPI scanners, the construction of 
which are previously described and analyzed16,17. These include a projection-format FFL scanner with 
2.35 × 2.35 T/m gradient, which achieves roughly 4 mm × 8 mm resolution along and orthogonal to the 
axis of the imaging bore respectively using undiluted Resovist tracer18. The FFL scanner’s projection-mode 
image acquisition enables fast scanning times on the order of seconds for a small animal-sized imaging 
Figure 1. MPI is a tracer imaging modality that can image tagged cells using time varying magnetic 
fields. (a) Diagram of a projection MPI scanner. Three superposed magnets (field-shifting magnets, gradient 
magnets, and transmit coil) produce and translate a magnetic field-free line (FFL) across an imaging volume. 
As the FFL is rastered across a distribution of superparamagnetic iron oxide (SPIO) particles using a spatial 
imaging trajectory, the particle ensemble magnetization changes in magnitude and orientation in response. 
The changing particle magnetization is detected via a detector coil and reconstructed to form an image.  
(b) Plot of MPI signal from 9 SPIO-labeled cell populations ranging from 1 × 104 to 1 × 106 cells, shown 
with MPI system noise floor. SPIO signal in MPI is linear with cell number (R2 = 0.994, linear fit and 95% 
confidence bounds for fitted slope shown). (c) Detection threshold for MPI cell tracking in FFL scanner. 
Approximately 1,000 SPIO-labeled hESC-derived cells in a 100 μ L in vitro suspension were imaged using 
MPI and compared to an empty scan. The signal-noise ratio of the image is estimated at above 5, giving a 
detection limit of approximately 200 cells. This represents the current detection sensitivity limit of our FFL 
MPI scanner, but the theoretical detection limit may be as low as a single cell. FOV: 6 cm × 8 cm. 20 second 
MPI acquisition. (d) MPI 1D line profile of Resovist-labeled cells and Resovist point sources. The FWHM 
resolution of the MPI signal is approximately 1.5-fold better for Resovist SPIO particles alone, at 5 mm, than 
for SPIO particles transfected into cells, at 7.7 mm. Scale bar: 1 cm. (e) MPI estimates for average cellular 
iron content (27.0 ± 3.3 pg/cell) correspond with ICP analysis (26.8 ± 0.3 pg/cell), making MPI useful for 
nondestructive iron quantification. n = 3 for ICP and n = 4 for MPI; results are mean ± SD.
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volume. We also report the use of a field-free point (FFP) MPI scanner with a 7 × 3.5 × 3.5 T/m gradi-
ent, which enables roughly 2 mm × 4 mm × 2 mm resolution using Resovist and higher resolution using 
MPI-tailored SPIOs17,19. An example MPI image of labeled cells scanned using the FFP scanner is shown 
in Fig. 2. Both scanners use our group’s recent advances in MPI reconstruction that are necessary and 
sufficient for linear quantification13. We also note that the experimental detection sensitivity of the FFL 
scanner is, at roughly 5 ng Fe/voxel, 15-fold better than the FFP scanner, as expected due to a larger voxel 
volume. Based on the high sensitivity and faster scan times of the FFL scanner, we conducted all MPI 
imaging in this study, with the exception of the image shown in Fig. 2, using the FFL scanner.
Results
Linear and Absolute Quantification. We first asked whether our MPI scanners could quantify 
SPIO-labeled cells in vitro. We modified an established MRI labeling protocol to label hESC-derived cells 
with Resovist SPIO tracer using a protamine sulfate transfection agent5. Both Resovist and protamine 
sulfate are approved for clinical use in the European Union and have no significant effect on cell prolif-
eration, viability, and differentiation5–7. Using the projection-mode MPI imager, we imaged nine labeled 
hESC-derived cell populations ranging from 1 × 104 to 1 × 106 cells. The normalized MPI signal was 
linear to the number of cells imaged (R2 > 0.994, Fig. 1b). In equivalent control cell populations without 
iron oxide labeling, no MPI signal was detected.
We further asked if MPI allows absolute quantification of iron oxide tracer. To determine this, we 
created a calibration curve using the MPI signal from measured volumes at 0, 0.3, and 1 μ L of Resovist 
SPIO tracer. We then used the calibration curve to estimate average cellular SPIO content in MPI images 
of 1 × 106 labeled cells. These MPI cellular iron estimates, at 27.0 ± 3.3 pg/cell, were within 99% agree-
ment (P = 0.923) with standard but destructive Inductively Coupled Plasma (ICP) measurements at 
26.8 ± 0.3 pg Fe/cell (Fig. 1e).
Sensitivity. We next investigated the sensitivity threshold of the prototype FFL MPI scanner for imag-
ing labeled cells. We imaged 1 × 103 in vitro tagged cells in a pellet using a 20 second projection MPI 
scan and reconstructed the final MPI image using only the second and third harmonics of the drive field 
frequency. The reconstructed image showed a signal-noise ratio (SNR) greater than 5, corresponding to 
a 200-cell (5.4 ng Fe) detection limit (Fig. 1c). This detection limit corresponds to 130 nM sensitivity for 
a measured voxel volume of 750 μ L.
Resolution. To assess the effect of SPIO cell labeling on MPI resolution, we acquired and compared a 
MPI line scan of two point sources: (a) 8 × 106 labeled hESC-derived cells and (b) 20 μ L of 10× diluted 
Resovist tracer (Fig. 1d). The point sources were placed 3.5 cm apart on a 3D printed sample holder. The 
point sources were small (1.3 mm width) compared to the native resolution of the FFL system. The axial 
dimension of the point sources did not affect resolution analysis because the axis of each vial was placed 
parallel to the FFL during imaging. After a native MPI image was acquired, a line profile was generated 
across the center of the sample image to assess image blurring (Fig. 1d, bottom panel). A comparison of 
the MPI signal widths of the two samples showed that the full-width-at-half-maximum (FWHM) reso-
lution of diluted Resovist particles in solution was 5 mm, approximately 1.5-fold better than that of the 
labeled cells at 7.7 mm. The measured native resolution for Resovist at 5 mm matches well with theory11, 
and approaches for improving the resolution are explored in Discussion.
Figure 2. FFP imaging of an acrylic phantom filled with six populations of SPIO-labeled cells. The MPI 
signal from cell populations (ranging from 4 × 105 to 1.6 × 106 in number) corresponds linearly to iron oxide 
tracer concentration, enabling quantitative imaging. Imaging parameters: 3.5 min acquisition on a 7 T/m 3D 
MPI scanner, 5 cm × 4.5 cm × 3 cm FOV. Scale bar: 1 cm.
www.nature.com/scientificreports/
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Longitudinal Cell Tracking. Last, we tested MPI for tracking neural progenitor cells (NPCs) in vivo, 
which have previously shown promise as treatments for Parkinson’s Disease, Huntington’s disease, epi-
lepsy and ischemia20. It is known that NPCs survive, migrate, and show reconstructive properties when 
implanted in rodent models of forebrain ischemia21,22. The high specificity of MPI for SPIO imaging 
would facilitate quantification of cell delivery and retention, leading to better understanding of dynamic 
events such as graft movement in such brain disease models.
To evaluate MPI for long-term tracking of neural implants, we stereotactically implanted 5 × 105 
SPIO-tagged hESC-derived NPCs in 5 μ L PBS solution in the forebrain of two immunosuppressed rats, 
representing a standard therapeutic dose for neural cell implants21–23. To assess MPI monitoring of cell 
graft mobility and clearance in vivo, we also implanted an equivalent number of labeled NPCs near the 
lateral ventricle of a third animal to facilitate translocation and potential clearance of the graft. 0.15 μ L 
Resovist tracer diluted in 4.85 μ L PBS was administered to the forebrain of a fourth animal as a control. 
Due to institutional policy, we began longitudinal imaging of the animals post-recovery at day 10 for 
animals 1–3 and day 4 for animal 4. We then monitored the graft signals using MPI imaging for a period 
of 87 days post-administration. Serial MPI images of cell grafts show high signal contrast with no detect-
able signal from surrounding anatomy (Fig. 3a). Figure 3b shows total MPI iron signal from the cell graft 
in animals 1-2 had non-significant decay over time. In contrast, the cell graft in animal 3 exhibited the 
presence of iron caudal/posterior to the implant site and significant iron clearance compared to animals 
1-2, suggesting movement and clearance of NPCs throughout the ventricle. The control animal receiving 
SPIO tracer alone showed no long-term detectable MPI signal.
Histological and MRI Validation. We then compared MPI cell tracking data to postmortem Prussian 
blue (PB) staining and MRI (Fig.  4). Animals 1 and 2 (Fig.  4a) showed the presence of SPIOs only at 
the injection site. In Animal 3, PB staining and MRI also revealed the presence of SPIOs adjacent to the 
lateral ventricle (Fig.  4c), which confirmed the MPI observation that tagged cells had migrated poste-
riorly throughout the ventricle. Additional postmortem PB staining did not show any residual iron in 
the brain of the animal that received tracer alone, indicating rapid tracer clearance seen in MPI images. 
Immunohistochemical staining against neural progenitor markers nestin, and human-specific neural cell 
adhesion molecule (NCAM), and human cytoplasmic marker SC121 confirmed the presence of human 
Figure 3. MPI quantitatively tracks NPC neural implants in rats over 87 days. (a) Longitudinal MPI 
imaging of 5 × 105 SPIO-labeled human NPCs implanted in the forebrain cortex (Animals 1-2), near 
lateral ventricle (Animal 3), and equivalent SPIO-only tracer in the forebrain cortex as control (Animal 4). 
MPI imaging quantifies graft clearance and movement over time, with rapid total clearance of SPIO-only 
injection (MPI: 30 sec acquisitions, 9.3 cm × 6 cm FOV, color intensity in ng/mm2, MRI reference: 10 min 
acquisitions, 7.5 cm × 4 cm, 384 × 384 matrix). All images are equally scaled; scale bar: 1 cm. (b) Total iron 
MPI estimates for in vivo cell grafts are plotted as a function of time with exponential fit. In vivo iron in 
Animal 1 and 2 do not show significant decrease over time, while iron signal was significantly decreased in 
Animal 3 starting Day 10. Animal 4 showed no long-term persistent MPI signal.
www.nature.com/scientificreports/
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SPIO-labeled cells at the administration site (Fig. 4b). Expression of the macrophage/microglial marker 
CD68 showed some immune cell infiltration within the grafts. CD68 staining also indicated the presence 
of iron-containing immune cells along the lateral ventricle in Animal 3, indicating immunogenicity as a 
mechanism of graft clearance.
Discussion
In this study, we describe the use of longitudinal in vivo MPI to track and quantify implanted neural cell 
grafts over three months. We also demonstrate that the MPI signal is linear and can be used to quantify 
cell number in vivo, and that our projection format MPI scanner has a detection sensitivity of as few 
as 200 cells in vitro. As a comparison, MRI, SPECT, PET, and fluorescent imaging are reported to have 
robust detection limits greater than 104 cells, with only bioluminescent imaging able to detect 103 cells 
superficially implanted in small animals3. We note that in the described prototype MPI scanners, noise in 
the detector coil preamplifier, at around 1 nV/√Hz, is not optimized and can be further improved by 1-2 
orders of magnitude. This preamplifier noise exceeds unwanted harmonic interference and is currently 
the dominant noise source in our MPI systems. Thus, with further instrumentation development, the 
true physical limit of in vivo detection for MPI may range between 1–10 cells at scanning times between 
seconds to minutes.
An area of promising research in MPI is improving the spatial resolution, now roughly 1 mm with 
a 7 T/m magnetic gradient. Here, we employed 2.35 T/m gradients for a FFL scanner, which yielded 
approximately 7 mm spatial resolution when imaging cells labeled with Resovist tracer. Spatial resolution 
in MPI is predicted to increase linearly with the gradient field strength and cubically with improved 
nanoparticles11. For example, previously published 22 nm particles enable double the image resolution 
of Resovist19, which behaves similar to a solid core 17 nm particle18. Many groups continue to develop 
MPI-optimized contrast agents for improved MPI resolution24–28.
Figure 4. Histological and MRI validation of iron location and quantification. (a) Histological 
analysis of NPC grafts. Postmortem Prussian blue (PB) staining confirms presence of iron-labeled cells at 
administration site but not for SPIO-only control (Animal 4). (b) Representative immunohistochemical 
slices (top right panels) are shown for NPC marker nestin (top left, Animal 1), neural cell adhesion molecule 
(top right, Animal 3), and human-specific cytoplasmic marker SC121 (bottom left, Animal 2), which 
indicate iron label within NPC grafts. CD68 staining (bottom right, Animal 3) also indicates immune cells at 
administration site, suggesting immune-based graft clearance. Scale bars: 100 μ m. (c) Postmortem axial MRI 
indicates iron in lateral ventricle in Animal 3 (arrow). PB and CD68 staining of lateral ventricle in Animal 
3 shows SPIO uptake by immune cells. MRI: 20 min acquisition, 2.56 cm isotropic FOV, 2563 pixel matrix. 
Scale bars: 1 mm.
www.nature.com/scientificreports/
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We routinely observed an intriguing change in MPI spatial resolution between Resovist tracer alone 
and Resovist-labeled cells, an effect also noted in previous studies on the MPI signal of SPIO-labeled 
red-blood cells29,30. Possible mechanisms for this resolution change could include size-selective endocy-
tosis of transfection agent-Fe complexes5,31, increased MPI relaxation effects due to increased intracel-
lular viscosity32,33, and transfection agent- mediated nanoparticle aggregation that may cause changes 
to the bulk particle magnetization and relaxation properties34–36. A better understanding of the mecha-
nism underlying this phenomenon would not only enable tailored nanoparticles for MPI cell tracking, 
but could also potentially be exploited to generate image contrast based on nanoparticle relaxation or 
clustering. For example, changes in particle relaxation due to changes in pH or viscosity may be used 
to differentiate between different physiological conditions in live and dead cell populations, detect cell 
apoptosis, or image in vivo uptake of SPIOs by immune cells.
It is clear that the direct detection of SPIO labels in MPI can enable studies that require longitudinal 
monitoring of cells in anatomy previously inaccessible to optical, MRI, and nuclear techniques, such 
as the GI tract, pulmonary vasculature, and near bone. MPI’s high image specificity for SPIOs enables 
visualizing systemic cell retention, migration, and biodistribution post-administration3. These systemic 
monitoring applications could include non-invasive probing of the immune system, such as the moni-
toring of labeled macrophages migrating to sites of inflammation3,37,38 and monitoring the fate of labeled 
T-cells used in immunotherapies. Finally, the SPIO labels and magnetic fields used in MPI have been 
shown to be human-safe17, enabling a clear path to clinical MPI translation.
Methods
Magnetic labeling of differentiated human embryonic stem cells (hESCs) and determination 
of labeling efficiency. H1 hESCs (WiCell, Madison, WI) were cultured on Matrigel-coated cell cul-
ture plates (BD, Franklin Lakes, NJ) in X-Vivo medium (Lonza, Norwalk, CT) supplemented with 80 ng/
mL FGF- 2 (PeproTech, Rocky Hill, NJ) and 0.5 ng/mL TGF-β 1 (R&D Systems, Minneapolis, MN), as 
described previously39.
For embryoid body (EB) mediated differentiation, H1 colonies were enzymatically isolated from 
Matrigel-coated plates by 5-minute treatment with 1 mg/mL collagenase type IV (Worthington 
Biochemical Corporation, Lakewood, NJ) and partially dissociated by gentle pipetting. The resulting cell 
clusters were resuspended in hESC culture medium, X-Vivo without FGF-2 and TGF-β 1, and transferred 
to ultra-low-attachment plates (Corning Incorporated, NY) for cell aggregation for 4 days. The generated 
EBs were then seeded on Matrigel-coated plates and allowed to differentiate for an additional 10–12 days 
in adherent conditions in X-Vivo medium.
For cell labeling, Resovist superparamagnetic iron oxide particles (Bayer Schering Pharma AG, 
Leverkusen, Germany; 0.5 mmol Fe/mL) at a concentration of 200 μ g Fe/mL were incubated with 6 μ g/mL 
protamine sulfate (American Pharmaceuticals Partner, Schaumburg, IL) in serum free X-Vivo medium 
(Lonza, Walkersville, MD) and allowed to form complexes on a shaker for 6 hr. The solution containing 
Fe-Pro complexes was added to differentiating hESCs in adherent culture condition. The cultures were 
incubated with Fe-Pro complexes overnight. Cultures after labeling were washed with 10 U/mL heparin 
(Sigma) in PBS three times to dissolve remaining surface-bound Fe-Pro complexes.
For assessment of labeling efficiency, Prussian blue cellular staining was performed by incubating 
cells, fixed with 4% paraformaldehyde, in a mixture of 4% potassium ferrocyanide and 3.7% HCl (Iron 
Stain Kit, Sigma) for 20 minutes to visualize intracellular iron particles. Cells were counted manually 
under a microscope to determine average cell labeling efficiency. Labeling efficiency was found to be 
71% + /− 8%. A hemocytometer was used to determine all cell numbers.
MPI image acquisition. Two custom-built MPI systems were used in this study: 1) a projection MPI 
scanner with 2.35 T/m/μ 0 field gradient18, and 2) a 3D MPI scanner with 7 T/m/μ 0. Both systems used 
a drive field frequency of 20.05 kHz and excitation strength of 40 mTpp/μ 0, with 30 second total scan 
time for projection MPI scanner and 3 minute scan time for 3D MPI scanner unless otherwise specified. 
MPI images were reconstructed using an x-space MPI reconstruction17,38,12, followed by light Wiener 
deconvolution using a measured point-spread function. All MPI images were windowed at 10% full 
scale. All data acquisition, control, and data processing were performed with MATLAB (Mathworks). All 
MPI imaging was conducted using the projection FFL scanner with the exception of the cell phantom 
imaging study shown in Fig. 2.
Determination of linearity of MPI signal with cell number. To investigate the linearity of the 
MPI signal with imaged cell number, we imaged 9 populations of Resovist-labeled hESC-derived cell 
pellets containing 10 × 103, 25 × 103, 50 × 103, 100 × 103, 200 × 103, 400 × 103, 600 × 103, 800 × 103, and 
1,000 × 103 cells using a projection-format MPI scanner as described above. Following image reconstruc-
tion, the maximum signal intensity for each MPI image was determined and the Pearson correlation 
coefficient was determined between normalized MPI signal and imaged cell number. Subsequent linear 
regression on the data and 95% confidence intervals for the slope of the regression line were determined.
Intracellular Iron Measurement. Average intracellular iron was determined using induction-coupled 
plasma optical emission spectrometry (Optima 5300 DV, PerkinElmer, Waltham, MA) on a population 
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of 1 × 106 SPIO-labeled hESC-derived cells. Prior to measurement, cells suspended in 0.2 mL PBS solu-
tion were digested using a 1.8 mL mixture of 70% nitric acid and 30% hydrogen peroxide and diluted to 
60 mL using deionized water. ICP analysis was performed in triplicate to determine intracellular iron as 
mean ± SD in picograms of iron per cell. Intracellular iron was also measured using MPI. A calibration 
curve for volume MPI signal per picogram iron was first generated using 0, 0.3, and 1.0 μ L Resovist 
tracer. Subsequently, we performed MPI imaging of 1 × 106 labeled cells (N = 4 each) and determined 
intracellular iron using the calibration curve as mean ± SD in picograms of iron per cell. To evaluate the 
congruence between MPI and ICP intracellular measurements, we performed an unpaired two-sample 
T-test for mean intracellular iron, with significance level set to 0.05.
In vivo stem cell implantation and MPI imaging. All animal procedures were conducted accord-
ing to the National Research Council’s Guide for the Care and Use of Laboratory Animals and approved 
by UC Berkeley’s Animal Care and Use Committee. Immunocompetent 8-week old female Fischer 344 
rats weighing 145 g were used for in vivo imaging. All animals were fed on an ad libitum diet of Teklad 
Rodent Diet 2018 (Harlan, Indianapolis, IL).
For in vivo MPI cell tracking experiments, hESCs were differentiated to neural progenitor cell by dual 
inhibition of SMAD signaling40 using SB431542 (10 μ M) and LDN-193189 (1 μ M) in adherent conditions 
for 12 days. The generated NPCs were labeled with Resovist SPIO particles as previously described here. 
The cell suspension contained approximately 100 × 103 viable cells/μ L.
Animals were anesthetized with an intraperitoneal injection of ketamine (100 mg/kg rat weight) 
and xylazine (7.5 mg/kg), positioned into a stereotactic frame. For two animals, a total of 500 × 103 
SPIO-labeled cells in 5 μ L were injected at the following stereotaxic coordinates: 1.0 mm AP (relative 
to Bregma), 2.0 mm lateral, 2.5 mm ventral (from dura) over 10 min using a Hamilton syringe at a rate 
of 0.5 μ L/min. For Animal 3, the coordinates were adjusted to 1.0 mm AP (relative to Bregma), 1.5 mm 
lateral, and 3.5 mm ventral (from dura). A control animal was injected using 0.15 μ L of Resovist tracer 
diluted in 4.85 μ L PBS using the same stereotactic coordinates as Animals 1-2. The needle was left in 
place for 3 min after injection and slowly removed. Animals were allowed to recover from surgery for 
up to ten days before MPI imaging, with 7 daily injections of cyclosporine-A starting 1 day prior to 
implantation at a dose of 15 mg/kg body weight.
Animals were imaged using MPI at days 10, 24, 35, 45, 59, and 87 post-implantation. Animal 4 was 
imaged at days 4 and 14 instead of days 10 and 24 with all other time points remaining the same. During 
in vivo MPI imaging, animals were induced into anesthesia using 2.5–3.0% isoflurane and maintained 
at 1.5% isoflurane at 2 L/min and placed in a custom-built animal bed in the MPI scanner. In vivo MPI 
scans were conducted on the projection MPI scanner using a 9.3 cm by 6 cm FOV with 30 second scan 
time.
For determination of in vivo SPIO clearance rates measured by MPI, a linear regression was per-
formed on the logarithm of the time-varying volumetric MPI signal for each animal.
Postmortem MRI. Ex vivo brains were imaged on a 7T Bruker PharmaScan MRI scanner using a 
ZTE pulse sequence. MR scans had total acquisition times of 20 minutes with 2563 voxels and 100 μ m3 
voxel size at 2.9 degree flip angles and 4 ms TR. Anatomical MRI images were acquired with postmor-
tem age-matched animals using a TurboRare pulse sequence with 10 minute acquisition and 3842 voxels, 
7.5 cm × 4 cm FOV, and 2.5 sec TR.
Stereology and Immunohistological Analysis. The brains were fixed in 4% paraformaldehyde 
overnight, then cryopreserved in 20% sucrose, frozen in dry ice, and cut in 40 μ m coronal sections 
using a microtome. For immunohistochemistry, the following primary antibodies were used: mouse 
anti-nestin (1:500, R&D system), SC121 (1:400, Stem Cells Inc.), mouse anti-CD68 (1:100, Abcam). 
Sections were then incubated with fluorescent-labeled secondary antibodies Alexa 488 (green) or Alexa 
568 (red)-labeled goat IgG; 1:1000, (Life Technologies) for 2 hr at room temperature and then mounted 
on glass slides. Brain slides were counter-stained with DAPI and imaged using a Zeiss Axio Observer A1 
inverted microscope or a confocal microscope (LSM 710, Zeiss).
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